Department of Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, United States ...

The findings offer promising support for progressing ADPO-002NP treatment to first-in-human Phase I clinical trials. Adipo ...

PHAT is a facial rejuvenation therapy that combines nanofat and its stem cells with PRP for anti-aging that lasts for more ...

Adipo Therapeutics LLC, a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and ...

Adipo Therapeutics LLC, a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and related metabolic disorders, presented data from two studies at the annual ...

“In individuals with obesity, the excess adipose tissue leads to a state of insulin resistance, which imposes stress on ...

The World Health Organization describes obesity as an epidemic that disrupts metabolic equilibrium, characterized by an ...

Obesity is an increasingly prevalent human condition in developed societies. Despite major progress in the understanding of the molecular mechanisms leading to obesity, no safe and effective ...

The uptake of CKGGRAKDC-FITC by the endothelium of white fat tissue suggests that the motif is preferentially internalized by a receptor in the adipose vasculature that may serve for targeted ...

For the quarter ended September 30, 2024, the Company had a loss from operations of $2.3 million, a 26% year-over-year improvement from $3.1 million for the comparable period of 2023, and a 9% ...

The discovery offers insight into why shift workers experience metabolic disruption, which could lead to new therapies for managing obesity and preventing muscle wasting. Recent research shows that ...

derived stem cells ("BADSC”) to generate brown adipose tissue ("BAT”), as well as exosomes secreted by BADSC. BAT is intended ...